FilingSEC EDGAR8-K
Skye Bioscience Regains Nasdaq Compliance and Announces CFO Resignation
· SEC accepted
StageListing Compliance and Executive Change
Filing content
The company regained compliance with Nasdaq's minimum bid price requirement, while CFO John P. Sharp resigned and the CEO assumed his financial duties.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…